Skip to main content

Peer Review reports

From: A trial platform to assess approved SARS-CoV-2 vaccines in immunocompromised patients: first sub-protocol for a pilot trial comparing the mRNA vaccines Comirnaty® and COVID-19 mRNA Vaccine Moderna®

Original Submission
19 May 2021 Submitted Original manuscript
2 Aug 2021 Reviewed Reviewer Report - Alexander Gough
26 Aug 2021 Author responded Author comments - Benjamin Speich
Resubmission - Version 2
26 Aug 2021 Submitted Manuscript version 2
9 Sep 2021 Reviewed Reviewer Report - Alexander Gough
Resubmission - Version 3
Submitted Manuscript version 3
15 Sep 2021 Editorially accepted
21 Oct 2021 Article published 10.1186/s13063-021-05664-0

You can find further information about peer review here.

Back to article page